Krystal Biotech (KRYS) News Today $126.45 +1.40 (+1.12%) Closing price 04:00 PM EasternExtended Trading$127.00 +0.55 (+0.43%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KRYS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Bank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Bank of America Corp DE cut its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 27.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 75,799 shares of the company's stock after sMay 25 at 3:19 AM | marketbeat.comPalisades Investment Partners LLC Purchases 3,436 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Palisades Investment Partners LLC boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,479 shares oMay 24 at 6:53 AM | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Frazier Life Sciences Management L.P.'s 4th Largest PositionFrazier Life Sciences Management L.P. lessened its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 20.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 788,460 shares of the company's stocMay 23, 2025 | marketbeat.comWoodline Partners LP Buys 41,287 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Woodline Partners LP lifted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 23.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 221,102 shares of the company's stock after buying an additional 41,287 sharMay 23, 2025 | marketbeat.comNuveen Asset Management LLC Has $47.64 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Nuveen Asset Management LLC reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 304,115 shares of the company's stoMay 22, 2025 | marketbeat.comDeutsche Bank AG Has $3.97 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Deutsche Bank AG boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 62.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,361 shares of the company's stock after acquiring anMay 22, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial MarketsBNP Paribas Financial Markets lowered its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 25.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,789 shares of the company's stock after selling 2,644 shares during the period. BNP PMay 22, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Soleus Capital Management L.P.'s 5th Largest PositionSoleus Capital Management L.P. lifted its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 65.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 358,379 shares of the company's stock after buying an addiMay 21, 2025 | marketbeat.comRafferty Asset Management LLC Sells 18,639 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Rafferty Asset Management LLC reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 40.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,201 shares of the company's stock after selling 18,639 shareMay 21, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 23,727 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Ameriprise Financial Inc. boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 26.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,476 shares of the companMay 19, 2025 | marketbeat.comCitigroup Issues Pessimistic Forecast for Krystal Biotech (NASDAQ:KRYS) Stock PriceMay 18, 2025 | americanbankingnews.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Reduced by Nicholas Investment Partners LPNicholas Investment Partners LP cut its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 73.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,086 shares of the company's stock after sellinMay 17, 2025 | marketbeat.comThe Analyst Verdict: Krystal Biotech In The Eyes Of 12 ExpertsMay 17, 2025 | benzinga.comPharma Fire Sale: 3 Stocks the RSI Says You Shouldn't IgnoreMay 14, 2025 | msn.comPharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore (KRYS)These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and nextMay 14, 2025 | marketbeat.comIntegral Health Asset Management LLC Makes New $8.62 Million Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)Integral Health Asset Management LLC acquired a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 55,000 shares of thMay 14, 2025 | marketbeat.comKrystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For ConservativelyMay 13, 2025 | finance.yahoo.comFY2025 EPS Estimates for Krystal Biotech Lowered by AnalystKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Analysts at Chardan Capital cut their FY2025 earnings per share (EPS) estimates for Krystal Biotech in a note issued to investors on Wednesday, May 7th. Chardan Capital analyst Y. Livshits now expects that the company will earn $5.50 per share fMay 13, 2025 | marketbeat.comDriehaus Capital Management LLC Has $19.07 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Driehaus Capital Management LLC reduced its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 25.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 121,702 shares of the company's stock after selling 41,602 shares during the period.May 11, 2025 | marketbeat.comNorthern Trust Corp Boosts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Northern Trust Corp grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 262,263 shares of the company's stock after acquiring an additional 23,572 sMay 11, 2025 | marketbeat.comHC Wainwright Forecasts Reduced Earnings for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at HC Wainwright dropped their Q2 2025 earnings per share estimates for Krystal Biotech in a research report issued on Tuesday, May 6th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earMay 10, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $5.52 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS)The Manufacturers Life Insurance Company grew its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 12.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 35,206 shares of the company's stock after purchasing an additionaMay 10, 2025 | marketbeat.comKrystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term GainMay 9, 2025 | insidermonkey.comKrystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term GainMay 9, 2025 | msn.comKrystal Biotech's (KRYS) Buy Rating Reiterated at Chardan CapitalChardan Capital reiterated a "buy" rating and set a $219.00 price target on shares of Krystal Biotech in a research report on Wednesday.May 9, 2025 | marketbeat.comKRYSTAL BIOTECH Earnings Results: $KRYS Reports Quarterly EarningsMay 8, 2025 | nasdaq.comKrystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $240.00 price objective on shares of Krystal Biotech in a research report on Tuesday.May 8, 2025 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Misses Expectations By $0.15 EPSKrystal Biotech (NASDAQ:KRYS - Get Free Report) issued its earnings results on Tuesday. The company reported $1.20 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.15). Krystal Biotech had a net margin of 30.69% and a return on equity of 11.41%.May 8, 2025 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Reaches New 12-Month Low Following Weak EarningsKrystal Biotech (NASDAQ:KRYS) Hits New 1-Year Low on Disappointing EarningsMay 8, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Boosted by Braidwell LPBraidwell LP grew its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 18.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 200,500 shares of the company's stock after buying an addMay 8, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of "Buy" by BrokeragesKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been assigned an average recommendation of "Buy" from the eight research firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, six have assigned a buyMay 8, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by Hsbc Holdings PLCHsbc Holdings PLC grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 195.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,519 shares of the company's stock after bMay 8, 2025 | marketbeat.comKrystal Biotech First Quarter 2025 Earnings: Misses ExpectationsMay 7, 2025 | finance.yahoo.comKrystal Biotech, Inc. (NASDAQ:KRYS) Q1 2025 Earnings Call TranscriptMay 7, 2025 | msn.comKrystal Biotech to Present at BofA Securities 2025 Health Care ConferenceMay 7, 2025 | globenewswire.comKrystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...May 7, 2025 | finance.yahoo.comKrystal Biotech shares tumble as Q1 results miss expectationsMay 6, 2025 | investing.comKrystal Biotech Announces First Quarter 2025 Financial and Operating ResultsMay 6, 2025 | finance.yahoo.comKrystal Biotech Shares Slip After 1Q MissMay 6, 2025 | marketwatch.comKrystal Biotech outlines 2025 global launch strategy with $88.2M Q1 VYJUVEK revenueMay 6, 2025 | msn.comKrystal Biotech, Inc. (KRYS) Q1 2025 Earnings Call TranscriptMay 6, 2025 | seekingalpha.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by First Trust Advisors LPFirst Trust Advisors LP trimmed its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 41.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,169 shares of the company's stock after selling 16,242May 5, 2025 | marketbeat.comChardan Capital Predicts Lower Earnings for Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at Chardan Capital lowered their FY2025 earnings estimates for shares of Krystal Biotech in a report issued on Tuesday, April 29th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earningMay 4, 2025 | marketbeat.comFY2026 EPS Estimates for Krystal Biotech Lifted by AnalystKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - HC Wainwright raised their FY2026 earnings per share estimates for shares of Krystal Biotech in a note issued to investors on Monday, April 28th. HC Wainwright analyst J. Pantginis now forecasts that the company will earn $6.30 per share for theMay 3, 2025 | marketbeat.comAquatic Capital Management LLC Invests $1.08 Million in Krystal Biotech, Inc. (NASDAQ:KRYS)Aquatic Capital Management LLC acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,901 shares of the company's stock, valued at apprMay 3, 2025 | marketbeat.comNebula Research & Development LLC Decreases Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Nebula Research & Development LLC reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 43.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,670 shares of the company's stock after selling 2,035 shares during the quarter. Nebula ResMay 2, 2025 | marketbeat.comKrystal Biotech (KRYS) Expected to Announce Quarterly Earnings on TuesdayKrystal Biotech (NASDAQ:KRYS) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-krystal-biotech-inc-stock/)May 1, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Holdings Boosted by Voya Investment Management LLCVoya Investment Management LLC grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 74,701 shares of the company's stock after purchasing an additional 4,123 sMay 1, 2025 | marketbeat.comDimensional Fund Advisors LP Cuts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Dimensional Fund Advisors LP lowered its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 588,599 shares of the company's stock aMay 1, 2025 | marketbeat.comMarshall Wace LLP Makes New $1.62 Million Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)Marshall Wace LLP purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 10,331 shares of the company's stock, valued at approximatelyMay 1, 2025 | marketbeat.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼1.501.02▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼97▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITCI News GMAB News RDY News VTRS News MRNA News ASND News QGEN News ROIV News RVMD News ELAN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRYS Stock Free KRYS Stock Alerts